A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)

Local Institution, Budapest

Belgyogyaszati Onkologia OOI, Budapest

Local Institution, La Tronche

Local Institution, Debrecen

Columbia University, New York

Local Institution, Caen

Fox Chase Cancer Center, Philadelphia

Istituto Clinico Humanitas, Rozzano (milano)

Irccs Ospedale S. Raffaele, Milan

Mayo Clinic Jacksonville, Jacksonville

Local Institution, Bordeaux

H. Lee Moffitt Cancer Center & Research Inst, Inc, Tampa

Local Institution, Rennes

Local Institution, Tours

Karmanos Cancer Institute, Detroit

Mayo Clinic Rochester, Rochester

Local Institution, Lille

Local Institution, Tel Aviv

Centre Hospitalier Lyon Sud - UPCO, Pierre-Bénite

Klinikum Stuttgart, Stuttgart

Baylor Research Institute, Dallas

Local Institution, Paris

City Of Hope Medical Center, Duarte

Local Institution, Jerusalem

Local Institution, Saint-Cloud

Swedish Medical Center, Seattle

Local Institution, Moscow

Local Institution, Singapore

Local Institution, Chuo-ku

Local Institution, Kotoku

Local Institution, Haifa

Local Institution, Hidaka-shi

Local Institution, Nagoya

Local Institution, Petah Tikva

Local Institution, Yamagata

University of Alabama at Birmingham, Birmingham

Dana Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston

Hackensack University Medical Center, Hackensack

Instituto Do Cancer Mae De Deus / Cor Hospital Mae De Deus, Porto Alegre

Fundacao Pio Xii Hosp Cancer De Barretos, Barretos

Hospital Das Clinicas - Fmusp, São Paulo

BC Cancer Agency - Vancouver Centre, Vancouver

Princess Margaret Cancer Centre, Toronto

CHU de Quebec, Québec

I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze, Prague

Local Institution, Hong Kong

Fondazione Policlinico Universitario A. Gemelli, Roma

Local Institution, Fukuoka

Local Institution, Mitaka-shi